We are live on
!
Find out more
GWM
GSB Wealth Management Portfolio holdings
AUM
$443M
1-Year Est. Return
17.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.02%
1 Year Est. Return
+17.59%
3 Year Est. Return
+45.9%
5 Year Est. Return
+57.79%
10 Year Est. Return
–
AUM
$21.1M
AUM Growth
-$954K
(-4.3%)
Cap. Flow
-$1.4M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
42.28%
Holding
58
New
2
Increased
5
Reduced
1
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNP Select Income Fund
DNP
|
+$470K |
| 2 |
DuPont de Nemours
DD
|
+$272K |
| 3 |
AbbVie
ABBV
|
+$206K |
| 4 |
Bank of America
BAC
|
+$3.79K |
| 5 |
Banco Santander
SAN
|
+$2.18K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$509K |
| 2 |
Abbott
ABT
|
+$437K |
| 3 |
Accenture
ACN
|
+$385K |
| 4 |
Paychex
PAYX
|
+$296K |
| 5 |
Johnson & Johnson
JNJ
|
+$267K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.02% |
| 2 | Healthcare | 12.17% |
| 3 | Consumer Staples | 12.14% |
| 4 | Energy | 10.88% |
| 5 | Utilities | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Banco Santander
SAN
$194B
| $101K | 0.48% |
15,212
+342
| +2% | +$2.18K |
|
|
PKD
52
DELISTED
Parker Drilling Company
PKD
| $46K | 0.22% |
2,822
| – | – |
|
|
53
Abbott
ABT
$180B
| – | – |
-9,000
| Closed | -$437K |
|
|
54
Accenture
ACN
$89.9B
| – | – |
-3,110
| Closed | -$385K |
|
|
55
AstraZeneca
AZN
$263B
| – | – |
-7,462
| Closed | -$509K |
|
56
JPMorgan Chase
JPM
$939B
| – | – |
-2,246
| Closed | -$205K |
|
|
57
Paychex
PAYX
$40.4B
| – | – |
-5,200
| Closed | -$296K |
|
|
DD
58
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-3,220
| Closed | -$260K |
|
Similar funds
CP
CMP
BFA
AC
TC
HBT
EFMC
TAS
GSB Wealth Management's Q3 2017 Portfolio in Review
As of Q3 2017, GSB Wealth Management held 58 positions worth $21.1M, down 4.3% from $22.1M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
GSB Wealth Management withdrew a net $1.4M in Q3 2017, closing 6 positions and reducing 1 holding. Its most notable exit was AstraZeneca, an estimated $509K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, GSB Wealth Management opened a new position in DuPont de Nemours worth $286K.
- GSB Wealth Management's largest Q3 2017 buy was DuPont de Nemours: 1,630 shares worth $286K.
- GSB Wealth Management added most to DNP Select Income Fund in Q3 2017, an estimated $470K increase.
- GSB Wealth Management's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $267K.
- GSB Wealth Management fully exited AstraZeneca in Q3 2017, selling an estimated $509K.
- GSB Wealth Management's ten largest holdings make up 42% of its $21.1M portfolio in Q3 2017.
- GSB Wealth Management opened 2 new positions and closed 6 in Q3 2017.
- GSB Wealth Management's portfolio value fell 4.3% quarter-over-quarter to $21.1M.
Based on GSB Wealth Management's 13F filing for Q3 2017, filed 24 Nov 2017.